SEC Filing Details

Document Details

Form
Filing Date
Feb 14, 2019
Document Date
Feb 14, 2019
Form Description
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
Filing Group
Registration Statements
Company
Turning Point Therapeutics, Inc.
Issuer
Turning Point Therapeutics, Inc.